Sax Wealth Advisors LLC Invests $328,000 in Intuitive Surgical, Inc. (NASDAQ:ISRG)

Sax Wealth Advisors LLC purchased a new stake in shares of Intuitive Surgical, Inc. (NASDAQ:ISRG - Free Report) during the fourth quarter, according to the company in its most recent disclosure with the Securities & Exchange Commission. The institutional investor purchased 629 shares of the medical equipment provider's stock, valued at approximately $328,000.

Other institutional investors and hedge funds also recently added to or reduced their stakes in the company. Merit Financial Group LLC boosted its stake in shares of Intuitive Surgical by 49.7% during the 4th quarter. Merit Financial Group LLC now owns 6,664 shares of the medical equipment provider's stock worth $3,478,000 after purchasing an additional 2,213 shares during the period. Relyea Zuckerberg Hanson LLC lifted its stake in Intuitive Surgical by 9.2% in the fourth quarter. Relyea Zuckerberg Hanson LLC now owns 606 shares of the medical equipment provider's stock worth $316,000 after purchasing an additional 51 shares during the last quarter. Avanza Fonder AB purchased a new position in shares of Intuitive Surgical during the fourth quarter valued at approximately $19,017,000. Wealthcare Advisory Partners LLC grew its stake in shares of Intuitive Surgical by 2.5% during the fourth quarter. Wealthcare Advisory Partners LLC now owns 4,004 shares of the medical equipment provider's stock valued at $2,090,000 after buying an additional 97 shares during the last quarter. Finally, Procyon Advisors LLC raised its holdings in shares of Intuitive Surgical by 7.8% in the fourth quarter. Procyon Advisors LLC now owns 6,744 shares of the medical equipment provider's stock worth $3,520,000 after buying an additional 487 shares during the period. Hedge funds and other institutional investors own 83.64% of the company's stock.

Intuitive Surgical Trading Up 1.5 %

ISRG traded up $8.56 during midday trading on Friday, hitting $592.64. 2,630,118 shares of the company traded hands, compared to its average volume of 1,158,623. The company has a market capitalization of $211.09 billion, a price-to-earnings ratio of 95.28, a PEG ratio of 4.66 and a beta of 1.39. Intuitive Surgical, Inc. has a 52-week low of $362.14 and a 52-week high of $597.68. The business has a 50 day simple moving average of $540.66 and a two-hundred day simple moving average of $499.19.

Intuitive Surgical (NASDAQ:ISRG - Get Free Report) last released its quarterly earnings data on Thursday, October 17th. The medical equipment provider reported $1.56 EPS for the quarter, beating analysts' consensus estimates of $1.24 by $0.32. Intuitive Surgical had a net margin of 28.51% and a return on equity of 13.41%. The company had revenue of $2.04 billion during the quarter, compared to the consensus estimate of $2.01 billion. Equities research analysts anticipate that Intuitive Surgical, Inc. will post 5.45 earnings per share for the current year.

Insider Buying and Selling

In other news, CFO Jamie Samath sold 108 shares of the stock in a transaction dated Tuesday, November 26th. The shares were sold at an average price of $542.06, for a total transaction of $58,542.48. Following the sale, the chief financial officer now owns 8,757 shares of the company's stock, valued at approximately $4,746,819.42. This represents a 1.22 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, CEO Gary S. Guthart sold 18,151 shares of Intuitive Surgical stock in a transaction that occurred on Wednesday, October 30th. The shares were sold at an average price of $511.63, for a total transaction of $9,286,596.13. Following the completion of the transaction, the chief executive officer now owns 24,219 shares of the company's stock, valued at $12,391,166.97. This trade represents a 42.84 % decrease in their position. The disclosure for this sale can be found here. Over the last three months, insiders sold 48,190 shares of company stock worth $25,012,927. Company insiders own 0.80% of the company's stock.

Wall Street Analyst Weigh In

Several research analysts have commented on ISRG shares. Evercore ISI restated a "cautious" rating on shares of Intuitive Surgical in a report on Friday, October 18th. Citigroup upped their target price on Intuitive Surgical from $567.00 to $640.00 and gave the stock a "buy" rating in a report on Wednesday, December 11th. Erste Group Bank upgraded Intuitive Surgical from a "hold" rating to a "buy" rating in a report on Tuesday, November 19th. JPMorgan Chase & Co. raised their price objective on Intuitive Surgical from $495.00 to $575.00 and gave the company an "overweight" rating in a research report on Friday, October 11th. Finally, Piper Sandler reiterated an "overweight" rating and issued a $538.00 target price (up from $495.00) on shares of Intuitive Surgical in a report on Friday, October 18th. One investment analyst has rated the stock with a sell rating, four have issued a hold rating and fifteen have issued a buy rating to the company. According to data from MarketBeat.com, the company presently has a consensus rating of "Moderate Buy" and a consensus price target of $554.17.

Intuitive Surgical Profile

Intuitive Surgical, Inc develops, manufactures, and markets products that enable physicians and healthcare providers to enhance the quality of and access to minimally invasive care in the United States and internationally. The company offers the da Vinci Surgical System that enables complex surgery using a minimally invasive approach; and Ion endoluminal system, which extends its commercial offerings beyond surgery into diagnostic procedures enabling minimally invasive biopsies in the lung.